金斯瑞生物科技(01548)通过受让人持有3亿股Probio Cayman A类优先股

智通财经
07 May

智通财经APP讯,金斯瑞生物科技(01548)发布公告,股份转让协议项下的所有交割条件均获满足且交割于2025年5月7日(交易时段后)进行。紧随交割后,本公司通过受让人持有3亿股Probio Cayman A类优先股。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10